HomeMRKR • NASDAQ
add
Marker Therapeutics Inc
Previous close
$1.46
Year range
$0.95 - $5.99
Market cap
16.52M USD
Avg Volume
169.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Barron's
19 minutes ago
Stocks Have Powered Past Big Risks This Year. How the Momentum Might Continue.
0.00%
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 349.10K | -71.94% |
Operating expense | 1.37M | 12.41% |
Net income | -4.45M | -85.81% |
Net profit margin | -1.27K | -562.16% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.69M | 20.93% |
Total assets | 16.99M | 20.59% |
Total liabilities | 2.50M | 8.58% |
Total equity | 14.49M | — |
Shares outstanding | 11.31M | — |
Price to book | 1.13 | — |
Return on assets | -53.25% | — |
Return on capital | -62.87% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.45M | -85.81% |
Cash from operations | -5.50M | -43.33% |
Cash from investing | — | — |
Cash from financing | 505.00 | -98.97% |
Net change in cash | -5.50M | -45.17% |
Free cash flow | -3.65M | -20.19% |
About
Founded
1992
Headquarters
Website
Employees
5
